0 items
Your cart is empty.
Elivena supplies Metabolic Peptides as research-grade compounds intended exclusively for qualified researchers, laboratories, and scientific institutions. This category replaces the previous Weight Loss & Metabolic Peptides category with terminology that better reflects controlled metabolic pathway research and avoids human-use implications.
Metabolic Peptides include compounds studied in metabolic signalling, incretin receptor pathway research, glucose-associated mechanisms, adipocyte cell systems, pancreatic beta-cell models, mitochondrial function analysis, AMPK-related pathway research, and cellular energy regulation.
Triple GIP/GLP-1/glucagon receptor agonist for metabolic support and weight management. 5mg vial.
Retatrutide 60 mg is used as treatment for chronic weight management and appetite imbalance
Semaglutide 2mg is used to treat weight gain and blood sugar imbalance in obese patients
GLP-1 receptor agonist for blood sugar regulation and effective weight management. 5mg vial.
GLP-1 receptor agonist for blood sugar regulation and effective weight management. 10mg vial.
Semaglutide 20 mg is used in the treatment of appetite imbalance and to support metabolic wellness
Semaglutide 50 mg is used in treatment of obese patients and to support healthy metabolic function
Survodutide 6mg supports metabolic health for obese patients and chronic weight management research
Dual GIP/GLP-1 receptor agonist for blood sugar control and significant weight reduction. 10mg.
Dual GIP/GLP-1 receptor agonist for blood sugar control and significant weight reduction. 15mg.
Tirzepatide 100 mg is used to treat chronic weight management and appetite control concerns
Tirzepatide 120 mg is used to treat obesity and support metabolic wellness goals in patients
We work with leading pharmaceutical brands specializing in Metabolic Peptides medications, selected for their clinical reliability, regulatory compliance, and consistent treatment outcomes.
Metabolic Peptides are classified according to documented molecular relevance to metabolic signalling systems and cellular energy-regulation models. These compounds may be studied as receptor ligands, pathway probes, or molecular research tools in defined experimental systems.
Research involving Metabolic Peptides may focus on incretin receptor activity, insulin-associated signalling, adipocyte pathway models, pancreatic beta-cell systems, mitochondrial function, and metabolic gene expression.
Classification is based on mechanistic research profiles only and does not imply therapeutic or clinical activity.
Metabolic Peptides may appear in studies involving incretin receptor systems and metabolic pathway models. Experimental endpoints may include:
These studies describe molecular activity in controlled laboratory systems.
Some Metabolic Peptides may be studied in glucose-associated pathway research or insulin signalling models. Research endpoints may include:
No findings from these models should be interpreted as effects on glucose control in humans.
Metabolic Peptides may also be investigated in adipocyte biology and mitochondrial bioenergetic research. Experimental areas may include:
These applications support metabolic pathway investigation in vitro only.
Researchers selecting Metabolic Peptides typically evaluate:
Elivena provides product specifications and quality documentation where available.
Elivena does not provide experimental design guidance, dosing information, administration instructions, or interpretation of research outcomes.
Metabolic Peptides are supplied as research-use-only biochemical compounds. Documentation may include:
Elivena does not supply these compounds for human or veterinary administration.
Survodutide 6mg supports metabolic health for obese patients and chronic weight management research
Mazdutide 10mg is treatment for appetite imbalance and support of healthy weight goals
HGH-derived lipolytic peptide targeting fat metabolism with no effect on blood sugar. 3mg vial.
